This report provides a comprehensive analysis of the global animal in vitro diagnostics (IVD) market, projecting significant growth through 2032. It examines key segments including diagnostic equipment, reagents, and advanced technologies like molecular diagnostics and immunoassays applied to companion animals and livestock. Driven by rising pet ownership and stringent livestock disease controls, the study explores market dynamics, competitive landscapes, and regional trends. Furthermore, it addresses technological challenges and the evolving shift toward digitalized, full-lifecycle animal health management.

Market Overview

Market Size and Growth Projections

The global Animal IVD market is projected to grow from US$ 7073 million in 2025 to US$ 11448 million in 2032. The market is expected to expand at a CAGR of 7.2% during the forecast period from 2026 to 2032. Additionally, the global animal IVD gross margin is projected to be between 25% and 45% by 2025.

Definition and Scope

Animal IVD refers to in vitro diagnostic technologies and products used to test animal biological samples—such as blood, urine, and tissue fluid—to identify or monitor animal diseases, health conditions, and physiological functions. The scope includes:

• Diagnostic kits
• Reagents
• Analytical instruments
• Molecular diagnostic equipment
• Immunoassay systems
• Related software

These tools are applied to disease detection and management across companion animals (pets), livestock, and other animal populations. Animal IVD supports veterinary clinical decision-making, early disease prevention and control, food safety assessment, and animal health monitoring by providing rapid, accurate, and reproducible test results. This improves the efficiency of veterinary services and plays a crucial role in enhancing animal quality of life, controlling zoonotic diseases, and optimizing livestock production.

Market Dynamics

Growth Drivers and Opportunities

The animal IVD market is experiencing unprecedented development opportunities driven by several factors:

• Pet Population & Awareness: Continuous growth in the global pet population and increasing awareness among pet owners regarding medical care.
• Livestock Industry Requirements: Stringent requirements for disease prevention and control within the livestock sector.
• Modern Healthcare Demands: Increasing demand for rapid, accurate, and intelligent diagnostic tools in veterinary clinics, laboratories, and research institutions, leading to the adoption of immunoassays, molecular diagnostics, and hematological analyses.
• Companion Animal Management: Diagnostic tools help identify infectious, chronic, and metabolic diseases in pets, improving treatment response monitoring.
• Evolution of Demand: Applications are shifting from traditional clinical testing toward full-lifecycle health management, including perinatal maternal health monitoring and farm herd health screening.
• Technological Integration: The development of portable and rapid testing, precise molecular diagnostics, and remote data interconnection, alongside the integration of diagnostic data with digital livestock management and smart veterinary services.

Market Challenges

Despite a promising outlook, the industry faces several pressing challenges:

• Technological & Cost Barriers: High complexity in testing systems creates cost barriers; developing high-value-added products like molecular diagnostics and intelligent interconnected devices requires significant investment and carries high entry barriers.
• Regulatory Heterogeneity: Significant differences in veterinary regulatory policies, testing standards, and quality certification systems across different countries and regions can impact cross-regional product promotion and pricing strategies.
• Competitive Pressure: Intensified competition in the low-to-mid-range diagnostic tools market may compress profit margins for certain companies.

Report Methodology and Scope

LPI (LP Information) Research Scope

LPI (LP Information)’s “Animal IVD Industry Forecast” report reviews total world Animal IVD sales in 2025 and provides a comprehensive analysis of projected sales for 2026 through 2032. The report provides detailed analysis in US$ millions, broken down by region, market sector, and sub-sector.

Analytical Focus

This Insight Report provides a comprehensive analysis of the global landscape, highlighting:

• Key trends in product segmentation, company formation, revenue, and market share.
• Latest developments and M&A activity.
• Strategies of leading global companies, including their Animal IVD portfolios, capabilities, market entry strategies, market positions, and geographic footprints.
• A breakdown of the forecast by Type, Application, Geography, and market size to identify emerging pockets of opportunity.
• A transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs.

Market Segmentation

By Type

• Equipment
• Reagents
• Others

By Animal

• Companion Animals
• Livestock
• Equine
• Others

By Technology

• Immunoassay
• Molecular Diagnostics
• Hematology
• Biochemistry Analysis
• Others

By Application

• Pet Hospital
• Livestock Farm
• Research Institute Animal Experiment Center
• Animal and Plant Quarantine Department
• Contract Research Organization
• Exotic/Wildlife Animals/Zoos

By Region

• Americas: United States, Canada, Mexico, Brazil
• APAC: China, Japan, Korea, Southeast Asia, India, Australia
• Europe: Germany, France, UK, Italy, Russia
• Middle East & Africa: Egypt, South Africa, Israel, Turkey, GCC Countries

Competitive Landscape

Key Players

The following companies have been profiled based on primary expert input and analysis of their coverage, product portfolio, and market penetration:

• IDEXX
• Zoetis
• Mars (Heska & Antech)
• Median Diagnostics
• Eurofins Ingenasa
• Bio-Rad
• Thermo Fisher Scientific
• Randox
• Innovative Diagnostics
• Edan
• Chengdu Seamaty Technology Co.,Ltd.
• Digifluidic
• Mindray Animal Medical
• Guangzhou Wondfo Biotech Co.,Ltd.
• Shenzhen Dymind Biotechnology Co., Ltd.
• Ustar Biotechnologies
• Genrui Biotech Inc.
• Micropoint Biotechnologies, Co., Ltd.
• MNCHIP
• Quicking Biotech Co., Ltd.
• Coyote Bioscience Co. Ltd
• Boehringer Ingelheim
• GZMED
• Sansure Biotech Inc.
• URIT Medical Electronic Co., Ltd
• Prokan
• TECOM
• Alovet Co., Ltd.

• 1 Scope of the Report

  • 1.1 Market Introduction

  • 1.2 Years Considered

  • 1.3 Research Objectives

  • 1.4 Market Research Methodology

  • 1.5 Research Process and Data Source

  • 1.6 Economic Indicators

  • 1.7 Currency Considered

  • 1.8 Market Estimation Caveats

• 2 Executive Summary

  • 2.1 World Market Overview

    • 2.1.1 Global Animal IVD Market Size (2021-2032)

    • 2.1.2 Animal IVD Market Size CAGR by Region (2021 VS 2025 VS 2032)

    • 2.1.3 World Current & Future Analysis for Animal IVD by Country/Region (2021, 2025 & 2032)

  • 2.2 Animal IVD Segment by Type

    • 2.2.1 Equipment

    • 2.2.2 Reagents

    • 2.2.3 Others

    • 2.2.4 Animal IVD Market Size by Type

      • 2.2.4.1 Animal IVD Market Size CAGR by Type (2021 VS 2025 VS 2032)
      • 2.2.4.2 Global Animal IVD Market Size Market Share by Type (2021-2026)

  • 2.3 Animal IVD Segment by Animal

    • 2.3.1 Companion Animals

    • 2.3.2 Livestock

    • 2.3.3 Equine

    • 2.3.4 Others

    • 2.3.5 Animal IVD Market Size by Animal

      • 2.3.5.1 Animal IVD Market Size CAGR by Animal (2021 VS 2025 VS 2032)
      • 2.3.5.2 Global Animal IVD Market Size Market Share by Animal (2021-2026)

  • 2.4 Animal IVD Segment by Technology

    • 2.4.1 Immunoassay

    • 2.4.2 Molecular Diagnostics

    • 2.4.3 Hematology

    • 2.4.4 Biochemistry Analysis

    • 2.4.5 Others

    • 2.4.6 Animal IVD Market Size by Technology

      • 2.4.6.1 Animal IVD Market Size CAGR by Technology (2021 VS 2025 VS 2032)
      • 2.4.6.2 Global Animal IVD Market Size Market Share by Technology (2021-2026)

  • 2.5 Animal IVD Segment by Application

    • 2.5.1 Pet Hospital

    • 2.5.2 Livestock Farm

    • 2.5.3 Research Institute Animal Experiment Center

    • 2.5.4 Animal and Plant Quarantine Department

    • 2.5.5 Contract Research Organization

    • 2.5.6 Exotic/Wildlife Animals/Zoos

    • 2.5.7 Animal IVD Market Size by Application

      • 2.5.7.1 Animal IVD Market Size CAGR by Application (2021 VS 2025 VS 2032)
      • 2.5.7.2 Global Animal IVD Market Size Market Share by Application (2021-2026)

• 3 Animal IVD Market Size by Player

  • 3.1 Animal IVD Market Size Market Share by Player

    • 3.1.1 Global Animal IVD Revenue by Player (2021-2026)

    • 3.1.2 Global Animal IVD Revenue Market Share by Player (2021-2026)

  • 3.2 Global Animal IVD Key Players Head office and Products Offered

  • 3.3 Market Concentration Rate Analysis

    • 3.3.1 Competition Landscape Analysis

    • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)

  • 3.4 New Products and Potential Entrants

  • 3.5 Mergers & Acquisitions, Expansion

• 4 Animal IVD by Region

  • 4.1 Animal IVD Market Size by Region (2021-2026)

  • 4.2 Global Animal IVD Annual Revenue by Country/Region (2021-2026)

  • 4.3 Americas Animal IVD Market Size Growth (2021-2026)

  • 4.4 APAC Animal IVD Market Size Growth (2021-2026)

  • 4.5 Europe Animal IVD Market Size Growth (2021-2026)

  • 4.6 Middle East & Africa Animal IVD Market Size Growth (2021-2026)

• 5 Americas

  • 5.1 Americas Animal IVD Market Size by Country (2021-2026)

  • 5.2 Americas Animal IVD Market Size by Type (2021-2026)

  • 5.3 Americas Animal IVD Market Size by Application (2021-2026)

  • 5.4 United States

  • 5.5 Canada

  • 5.6 Mexico

  • 5.7 Brazil

• 6 APAC

  • 6.1 APAC Animal IVD Market Size by Region (2021-2026)

  • 6.2 APAC Animal IVD Market Size by Type (2021-2026)

  • 6.3 APAC Animal IVD Market Size by Application (2021-2026)

  • 6.4 China

  • 6.5 Japan

  • 6.6 South Korea

  • 6.7 Southeast Asia

  • 6.8 India

  • 6.9 Australia

• 7 Europe

  • 7.1 Europe Animal IVD Market Size by Country (2021-2026)

  • 7.2 Europe Animal IVD Market Size by Type (2021-2026)

  • 7.3 Europe Animal IVD Market Size by Application (2021-2026)

  • 7.4 Germany

  • 7.5 France

  • 7.6 UK

  • 7.7 Italy

  • 7.8 Russia

• 8 Middle East & Africa

  • 8.1 Middle East & Africa Animal IVD by Region (2021-2026)

  • 8.2 Middle East & Africa Animal IVD Market Size by Type (2021-2026)

  • 8.3 Middle East & Africa Animal IVD Market Size by Application (2021-2026)

  • 8.4 Egypt

  • 8.5 South Africa

  • 8.6 Israel

  • 8.7 Turkey

  • 8.8 GCC Countries

• 9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities

  • 9.2 Market Challenges & Risks

  • 9.3 Industry Trends

• 10 Global Animal IVD Market Forecast

  • 10.1 Global Animal IVD Forecast by Region (2027-2032)

    • 10.1.1 Global Animal IVD Forecast by Region (2027-2032)

    • 10.1.2 Americas Animal IVD Forecast

    • 10.1.3 APAC Animal IVD Forecast

    • 10.1.4 Europe Animal IVD Forecast

    • 10.1.5 Middle East & Africa Animal IVD Forecast

  • 10.2 Americas Animal IVD Forecast by Country (2027-2032)

    • 10.2.1 United States Market Animal IVD Forecast

    • 10.2.2 Canada Market Animal IVD Forecast

    • 10.2.3 Mexico Market Animal IVD Forecast

    • 10.2.4 Brazil Market Animal IVD Forecast

  • 10.3 APAC Animal IVD Forecast by Region (2027-2032)

    • 10.3.1 China Animal IVD Market Forecast

    • 10.3.2 Japan Market Animal IVD Forecast

    • 10.3.3 Korea Market Animal IVD Forecast

    • 10.3.4 Southeast Asia Market Animal IVD Forecast

    • 10.3.5 India Market Animal IVD Forecast

    • 10.3.6 Australia Market Animal IVD Forecast

  • 10.4 Europe Animal IVD Forecast by Country (2027-2032)

    • 10.4.1 Germany Market Animal IVD Forecast

    • 10.4.2 France Market Animal IVD Forecast

    • 10.4.3 UK Market Animal IVD Forecast

    • 10.4.4 Italy Market Animal IVD Forecast

    • 10.4.5 Russia Market Animal IVD Forecast

  • 10.5 Middle East & Africa Animal IVD Forecast by Region (2027-2032)

    • 10.5.1 Egypt Market Animal IVD Forecast

    • 10.5.2 South Africa Market Animal IVD Forecast

    • 10.5.3 Israel Market Animal IVD Forecast

    • 10.5.4 Turkey Market Animal IVD Forecast

  • 10.6 Global Animal IVD Forecast by Type (2027-2032)

  • 10.7 Global Animal IVD Forecast by Application (2027-2032)

    • 10.7.1 GCC Countries Market Animal IVD Forecast

• 11 Key Players Analysis

  • 11.1 IDEXX

    • 11.1.1 IDEXX Company Information

    • 11.1.2 IDEXX Animal IVD Product Offered

    • 11.1.3 IDEXX Animal IVD Revenue, Gross Margin and Market Share (2021-2026)

    • 11.1.4 IDEXX Main Business Overview

    • 11.1.5 IDEXX Latest Developments

  • 11.2 Zoetis

    • 11.2.1 Zoetis Company Information

    • 11.2.2 Zoetis Animal IVD Product Offered

    • 11.2.3 Zoetis Animal IVD Revenue, Gross Margin and Market Share (2021-2026)

    • 11.2.4 Zoetis Main Business Overview

    • 11.2.5 Zoetis Latest Developments

  • 11.3 Mars (Heska & Antech)

    • 11.3.1 Mars (Heska & Antech) Company Information

    • 11.3.2 Mars (Heska & Antech) Animal IVD Product Offered

    • 11.3.3 Mars (Heska & Antech) Animal IVD Revenue, Gross Margin and Market Share (2021-2026)

    • 11.3.4 Mars (Heska & Antech) Main Business Overview

    • 11.3.5 Mars (Heska & Antech) Latest Developments

  • 11.4 Median Diagnostics

    • 11.4.1 Median Diagnostics Company Information

    • 11.4.2 Median Diagnostics Animal IVD Product Offered

    • 11.4.3 Median Diagnostics Animal IVD Revenue, Gross Margin and Market Share (2021-2026)

    • 11.4.4 Median Diagnostics Main Business Overview

    • 11.4.5 Median Diagnostics Latest Developments

  • 11.5 Eurofins Ingenasa

    • 11.5.1 Eurofins Ingenasa Company Information

    • 11.5.2 Eurofins Ingenasa Animal IVD Product Offered

    • 11.5.3 Eurofins Ingenasa Animal IVD Revenue, Gross Margin and Market Share (2021-2026)

    • 11.5.4 Eurofins Ingenasa Main Business Overview

    • 11.5.5 Eurofins Ingenasa Latest Developments

  • 11.6 Bio-Rad

    • 11.6.1 Bio-Rad Company Information

    • 11.6.2 Bio-Rad Animal IVD Product Offered

    • 11.6.3 Bio-Rad Animal IVD Revenue, Gross Margin and Market Share (2021-2026)

    • 11.6.4 Bio-Rad Main Business Overview

    • 11.6.5 Bio-Rad Latest Developments

  • 11.7 Thermo Fisher Scientific

    • 11.7.1 Thermo Fisher Scientific Company Information

    • 11.7.2 Thermo Fisher Scientific Animal IVD Product Offered

    • 11.7.3 Thermo Fisher Scientific Animal IVD Revenue, Gross Margin and Market Share (2021-2026)

    • 11.7.4 Thermo Fisher Scientific Main Business Overview

    • 11.7.5 Thermo Fisher Scientific Latest Developments

  • 11.8 Randox

    • 11.8.1 Randox Company Information

    • 11.8.2 Randox Animal IVD Product Offered

    • 11.8.3 Randox Animal IVD Revenue, Gross Margin and Market Share (2021-2026)

    • 11.8.4 Randox Main Business Overview

    • 11.8.5 Randox Latest Developments

  • 11.9 Innovative Diagnostics

    • 11.9.1 Innovative Diagnostics Company Information

    • 11.9.2 Innovative Diagnostics Animal IVD Product Offered

    • 11.9.3 Innovative Diagnostics Animal IVD Revenue, Gross Margin and Market Share (2021-2026)

    • 11.9.4 Innovative Diagnostics Main Business Overview

    • 11.9.5 Innovative Diagnostics Latest Developments

  • 11.10 Edan

    • 11.10.1 Edan Company Information

    • 11.10.2 Edan Animal IVD Product Offered

    • 11.10.3 Edan Animal IVD Revenue, Gross Margin and Market Share (2021-2026)

    • 11.10.4 Edan Main Business Overview

    • 11.10.5 Edan Latest Developments

  • 11.11 Chengdu Seamaty Technology Co.,Ltd.

    • 11.11.1 Chengdu Seamaty Technology Co.,Ltd. Company Information

    • 11.11.2 Chengdu Seamaty Technology Co.,Ltd. Animal IVD Product Offered

    • 11.11.3 Chengdu Seamaty Technology Co.,Ltd. Animal IVD Revenue, Gross Margin and Market Share (2021-2026)

    • 11.11.4 Chengdu Seamaty Technology Co.,Ltd. Main Business Overview

    • 11.11.5 Chengdu Seamaty Technology Co.,Ltd. Latest Developments

  • 11.12 Digifluidic

    • 11.12.1 Digifluidic Company Information

    • 11.12.2 Digifluidic Animal IVD Product Offered

    • 11.12.3 Digifluidic Animal IVD Revenue, Gross Margin and Market Share (2021-2026)

    • 11.12.4 Digifluidic Main Business Overview

    • 11.12.5 Digifluidic Latest Developments

  • 11.13 Mindray Animal Medical

    • 11.13.1 Mindray Animal Medical Company Information

    • 11.13.2 Mindray Animal Medical Animal IVD Product Offered

    • 11.13.3 Mindray Animal Medical Animal IVD Revenue, Gross Margin and Market Share (2021-2026)

    • 11.13.4 Mindray Animal Medical Main Business Overview

    • 11.13.5 Mindray Animal Medical Latest Developments

  • 11.14 Guangzhou Wondfo Biotech Co.,Ltd.

    • 11.14.1 Guangzhou Wondfo Biotech Co.,Ltd. Company Information

    • 11.14.2 Guangzhou Wondfo Biotech Co.,Ltd. Animal IVD Product Offered

    • 11.14.3 Guangzhou Wondfo Biotech Co.,Ltd. Animal IVD Revenue, Gross Margin and Market Share (2021-2026)

    • 11.14.4 Guangzhou Wondfo Biotech Co.,Ltd. Main Business Overview

    • 11.14.5 Guangzhou Wondfo Biotech Co.,Ltd. Latest Developments

  • 11.15 Shenzhen Dymind Biotechnology Co., Ltd.

    • 11.15.1 Shenzhen Dymind Biotechnology Co., Ltd. Company Information

    • 11.15.2 Shenzhen Dymind Biotechnology Co., Ltd. Animal IVD Product Offered

    • 11.15.3 Shenzhen Dymind Biotechnology Co., Ltd. Animal IVD Revenue, Gross Margin and Market Share (2021-2026)

    • 11.15.4 Shenzhen Dymind Biotechnology Co., Ltd. Main Business Overview

    • 11.15.5 Shenzhen Dymind Biotechnology Co., Ltd. Latest Developments

  • 11.16 Ustar Biotechnologies

    • 11.16.1 Ustar Biotechnologies Company Information

    • 11.16.2 Ustar Biotechnologies Animal IVD Product Offered

    • 11.16.3 Ustar Biotechnologies Animal IVD Revenue, Gross Margin and Market Share (2021-2026)

    • 11.16.4 Ustar Biotechnologies Main Business Overview

    • 11.16.5 Ustar Biotechnologies Latest Developments

  • 11.17 Genrui Biotech Inc.

    • 11.17.1 Genrui Biotech Inc. Company Information

    • 11.17.2 Genrui Biotech Inc. Animal IVD Product Offered

    • 11.17.3 Genrui Biotech Inc. Animal IVD Revenue, Gross Margin and Market Share (2021-2026)

    • 11.17.4 Genrui Biotech Inc. Main Business Overview

    • 11.17.5 Genrui Biotech Inc. Latest Developments

  • 11.18 Micropoint Biotechnologies,Co.,Ltd.

    • 11.18.1 Micropoint Biotechnologies,Co.,Ltd. Company Information

    • 11.18.2 Micropoint Biotechnologies,Co.,Ltd. Animal IVD Product Offered

    • 11.18.3 Micropoint Biotechnologies,Co.,Ltd. Animal IVD Revenue, Gross Margin and Market Share (2021-2026)

    • 11.18.4 Micropoint Biotechnologies,Co.,Ltd. Main Business Overview

    • 11.18.5 Micropoint Biotechnologies,Co.,Ltd. Latest Developments

  • 11.19 MNCHIP

    • 11.19.1 MNCHIP Company Information

    • 11.19.2 MNCHIP Animal IVD Product Offered

    • 11.19.3 MNCHIP Animal IVD Revenue, Gross Margin and Market Share (2021-2026)

    • 11.19.4 MNCHIP Main Business Overview

    • 11.19.5 MNCHIP Latest Developments

  • 11.20 Quicking Biotech Co., Ltd.

    • 11.20.1 Quicking Biotech Co., Ltd. Company Information

    • 11.20.2 Quicking Biotech Co., Ltd. Animal IVD Product Offered

    • 11.20.3 Quicking Biotech Co., Ltd. Animal IVD Revenue, Gross Margin and Market Share (2021-2026)

    • 11.20.4 Quicking Biotech Co., Ltd. Main Business Overview

    • 11.20.5 Quicking Biotech Co., Ltd. Latest Developments

  • 11.21 Coyote Bioscience Co.Ltd

    • 11.21.1 Coyote Bioscience Co.Ltd Company Information

    • 11.21.2 Coyote Bioscience Co.Ltd Animal IVD Product Offered

    • 11.21.3 Coyote Bioscience Co.Ltd Animal IVD Revenue, Gross Margin and Market Share (2021-2026)

    • 11.21.4 Coyote Bioscience Co.Ltd Main Business Overview

    • 11.21.5 Coyote Bioscience Co.Ltd Latest Developments

  • 11.22 Boehringer Ingelheim

    • 11.22.1 Boehringer Ingelheim Company Information

    • 11.22.2 Boehringer Ingelheim Animal IVD Product Offered

    • 11.22.3 Boehringer Ingelheim Animal IVD Revenue, Gross Margin and Market Share (2021-2026)

    • 11.22.4 Boehringer Ingelheim Main Business Overview

    • 11.22.5 Boehringer Ingelheim Latest Developments

  • 11.23 GZMED

    • 11.23.1 GZMED Company Information

    • 11.23.2 GZMED Animal IVD Product Offered

    • 11.23.3 GZMED Animal IVD Revenue, Gross Margin and Market Share (2021-2026)

    • 11.23.4 GZMED Main Business Overview

    • 11.23.5 GZMED Latest Developments

  • 11.24 Sansure Biotech Inc.

    • 11.24.1 Sansure Biotech Inc. Company Information

    • 11.24.2 Sansure Biotech Inc. Animal IVD Product Offered

    • 11.24.3 Sansure Biotech Inc. Animal IVD Revenue, Gross Margin and Market Share (2021-2026)

    • 11.24.4 Sansure Biotech Inc. Main Business Overview

    • 11.24.5 Sansure Biotech Inc. Latest Developments

  • 11.25 URIT Medical Electronic Co., Ltd

    • 11.25.1 URIT Medical Electronic Co., Ltd Company Information

    • 11.25.2 URIT Medical Electronic Co., Ltd Animal IVD Product Offered

    • 11.25.3 URIT Medical Electronic Co., Ltd Animal IVD Revenue, Gross Margin and Market Share (2021-2026)

    • 11.25.4 URIT Medical Electronic Co., Ltd Main Business Overview

    • 11.25.5 URIT Medical Electronic Co., Ltd Latest Developments

  • 11.26 Prokan

    • 11.26.1 Prokan Company Information

    • 11.26.2 Prokan Animal IVD Product Offered

    • 11.26.3 Prokan Animal IVD Revenue, Gross Margin and Market Share (2021-2026)

    • 11.26.4 Prokan Main Business Overview

    • 11.26.5 Prokan Latest Developments

  • 11.27 TECOM

    • 11.27.1 TECOM Company Information

    • 11.27.2 TECOM Animal IVD Product Offered

    • 11.27.3 TECOM Animal IVD Revenue, Gross Margin and Market Share (2021-2026)

    • 11.27.4 TECOM Main Business Overview

    • 11.27.5 TECOM Latest Developments

  • 11.28 Alovet Co., Ltd.

    • 11.28.1 Alovet Co., Ltd. Company Information

    • 11.28.2 Alovet Co., Ltd. Animal IVD Product Offered

    • 11.28.3 Alovet Co., Ltd. Animal IVD Revenue, Gross Margin and Market Share (2021-2026)

    • 11.28.4 Alovet Co., Ltd. Main Business Overview

    • 11.28.5 Alovet Co., Ltd. Latest Developments

• 12 Research Findings and Conclusion